BACKGROUND: @entity924 ( @entity924 ) represents a triad of @entity158 , @entity4 and impaired performance. Extracorporeal shockwave therapy (ESWT) has been endorsed by the National Institute for Health and Care Excellence (NICE) for refractory @entity924 . This audit investigates the long-term outcomes of @entity1 treated with ESWT for refractory @entity924 . METHODS: Forty-six @entity1 treated with ESWT for @entity924 between October 2010 and August 2011 completed visual analogue, satisfaction scores and functional assessment questionnaires over two years. @entity1 were subdivided into two groups depending on whether their @entity924 was insertional (IAT) or non-insertional ( @entity45859 ). RESULTS: Forty-six @entity1 (mean age 58 years) completed all treatments and full 2 year follow up. There was significant improvement in @entity158 at rest, on activity and of function within both @entity45859 and IAT groups over the two-year period. Satisfaction scores were significant in the @entity45859 group but not in the IAT group. CONCLUSIONS: ESWT appears to be of benefit in the long term improvement of @entity158 at rest, on activity and functional outcome in @entity1 with refractory @entity924 . However, subjective @entity1 opinion may not match the perceived clinical outcome observed in this audit in all @entity1 and individuals should be counselled regarding this prior to treatment.

Extracorporeal shockwave therapy (ESWT) for XXXX : A prospective audit with 2-year follow up.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity45859 :: ('6046', 'Gene') :: ['NAT'] @entity4 :: ('MESH:D004487', 'Disease') :: ['swelling'] @entity924 :: ('MESH:D052256', 'Disease') :: ['Achilles tendinopathy', 'AT'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain', 'tendon pain']
@entity924 :: (MESH:D052256,Disease) :: ['refractory Achilles tendinopathy']
